Table 4.

Result of multiple linear logistic regression analysis of various TSHRAb activities predicting the presence of ophthalmopathy in patients with Graves’ disease

Variable	Wald	R	Significance
TSBAb (%)	6.040	0.156	0.014
CHO TSAb (%)	0.017	0.000	0.896
FRTL-5 TSAb (%)	3.300	0.088	0.069
TBII (%)	2.466	0.053	0.116
Mc1+2 TSAb (%)	0.602	0.000	0.438
Mc2 TSAb (%)	0.550	0.000	0.459

TSBAb ; Blocking TSHRAb activities measured by Mc2 cells

CHO-TSAb ; Stimulating TSHRAb activities measured by wild-type CHO-hTSHR cells

FRTL-5 TSAb ; Stimulating TSHRAb activities measured by FRTL-5 cells

Mc1+2 TSAb ; Stimulating TSHRAb activities measured by Mc1+2 cells

Mc 2 TSAb ; Stimulating TSHRAb activities measured by Mc 2 cells

TBII ; Thyrotropin binding inhibitor immunoglobulin